86.22.Z - Specialist medical practice activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
82.19.Z - Photocopying, document preparation and other specialised office support activities
82.30.Z - Organisation of conventions and trade shows
85.59.B - Other out-of-school forms of education, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,2 | 0,2 | 10,6 |
EBITDA | 0,1 | 0,2 | 0,3 | 8,5 |
Short time liabilities | 0,1 | 0,1 | 0 | -23,5 |
Equity capital | 1 | 1,2 | 1,3 | 10,8 |
Operating profit (EBIT) | 0 | 0,2 | 0,2 | 9,3 |
Assets | 1,2 | 1,4 | 1,5 | 9,2 |
Net profit (loss) | 0 | 0,2 | 0,2 | 12 |
Cash | 0,3 | 0,4 | 0,6 | 38,6 |
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,2 | -1,8 |
Net income from sale | 1 | 1,3 | 1,6 | 18,3 |
Working assets | 0,4 | 0,6 | 0,8 | 23,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 3,7 | 15,6 | 15,8 | 0,2 |
Equity capital to total assets | 90,4 | 87,5 | 88,7 | 1,2 |
Gross profit margin | 4,2 | 15,5 | 14,5 | -1 |
EBITDA Margin | 6,2 | 18,1 | 16,6 | -1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 17 | 11 | -6 |
Current financial liquidity indicator | 3.544461250305176 | -8,4 | ||
Net dept to EBITDA | -4.017417907714844 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane